Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CDE vs GSK✓SelectedUSD · GSKCDE vs GSK performance historyLatest closeAs of-7.45%11/20
Stock and ETF performance explorer

CDE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-94.7%
GSK return
+1,644.3%
Excess return
-1,739.0%
Maximum drawdown
-99.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.5%-0.1%-7.3%-7.4%
7D-23.6%-5.3%-18.3%-22.7%
30D-29.4%-3.7%-25.8%-28.8%
3M-49.4%-7.3%-42.2%-48.7%
6M-39.7%-4.2%-35.5%-39.4%
YTD-40.0%+0.9%-40.9%-40.5%
1Y-22.9%+7.3%-30.1%-24.5%
3Y+317.7%+52.7%+264.9%+271.9%
5Y+67.1%+40.1%+26.9%+51.6%
10Y+9.5%+98.7%-89.2%-6.1%
All-94.7%+1,644.3%-1,739.0%-94.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling